-
Product Insights
Lafora Disease (Unverricht Disease) - Drugs In Development, 2024
Empower your strategies with our Lafora Disease (Unverricht Disease) – Drugs In Development, 2024 report and make more profitable business decisions. Unverricht-Lundborg disease (EPM1) a rare and fatal genetic neurodegenerative disorder that causes progressive myoclonic epilepsy. It is caused by mutations of the cystatin B gene. It typically presents in adolescents with new onset seizures along with symptoms such as lack of motor coordination, impaired mental function, and depression. It is diagnosed with a skin biopsy that shows Lafora bodies in...
-
Product Insights
Infantile Spasm (West Syndrome) - Drugs In Development, 2024
Empower your strategies with our Infantile Spasm (West Syndrome) – Drugs In Development, 2024 report and make more profitable business decisions. Infantile Spasm also known as West Syndrome is a type of seizures and most seen in children. Observed in children up to 5 years of age and can develop into other seizures in rare cases. Sudden stiffening of arms and legs, head thrown back, commonly observed when woke up from sleep and rare in sleep. These seizures last for four...
-
Product Insights
Status Epilepticus - Drugs In Development, 2024
Empower your strategies with our Status Epilepticus – Drugs In Development, 2024 report and make more profitable business decisions. Status epilepticus is an emergency neurological condition where seizures last for more than five minutes; historically, it was diagnosed for seizures longer than than 30 minutes. Patients with this condition do not regain consciousness between seizures, which can lead to death. Hence, it requires immediate emergency evaluation and management. Seizures can be convulsive or non-convulsive, and are most commonly observed in pediatric...
-
Product Insights
Myoclonic Seizure - Drugs In Development, 2024
Empower your strategies with our Myoclonic Seizure – Drugs In Development, 2024 report and make more profitable business decisions. Myoclonic seizures cause a quick, uncontrollable muscle movement with no change in level of awareness or consciousness. They are characterized by brief, jerking spasms of a muscle or a group of related muscles, but can sometimes affect wider areas of body. The Myoclonic Seizure drugs in development market research report provide comprehensive information on the therapeutics under development for Myoclonic Seizure, complete...
-
Product Insights
Tonic-Clonic (Grand Mal) Seizure - Drugs In Development, 2024
Empower your strategies with our Tonic-Clonic (Grand Mal) Seizure – Drugs In Development, 2024 report and make more profitable business decisions. A tonic-clonic seizure, previously known as a grand mal seizure, is defined as a seizure that has a tonic phase followed by clonic muscle contractions that causes a loss of consciousness and violent muscle contractions. The Tonic-Clonic (Grand Mal) Seizure drugs in development market research report provide comprehensive information on the therapeutics under development for Tonic-Clonic (Grand Mal) Seizure, complete...
-
Sector Analysis
Lennox-Gastaut Syndrome (LGS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Lennox-Gastaut Syndrome (LGS) Marketed and Pipeline Drugs Report Overview Lennox-Gastaut Syndrome (LGS) is a severe form of epilepsy that typically becomes apparent during infancy or early childhood. Affected children experience several different types of seizures, such as atonic, tonic, and atypical absence seizures. Children with LGS may also develop cognitive dysfunction, delays in reaching developmental milestones, and behavioral problems. Key Mechanism of Action (Marketed) ·       Receptor Agonists ·       Ion Channel Blockers ·       Enzyme Inhibitors ·       Receptor Antagonists ·       Transporter Inhibitors...
-
Sector Analysis
Dravet Syndrome (DS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Dravet Syndrome (DS) Marketed and Pipeline Drugs Report Overview Dravet syndrome is also known as severe myoclonic epilepsy of infancy (SMEI). It is a rare and severe form of epilepsy that typically begins in the first year of life. The exact cause of Dravet syndrome is usually genetic. However, seizures in affected individuals can be triggered by various factors including fever, infections, and sometimes vaccinations. These triggers can lead to prolonged and potentially life-threatening seizures known as status epilepticus. Genetic...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.